Muscle Cell News Volume 6.14 | Apr 19 2021

    0
    37







    2021-04-19 | MUSCN 6.14


    Muscle Cell News by STEMCELL Technologies
    Vol. 6.14 – 19 April, 2021
    TOP STORY

    A Form of Muscular Dystrophy Associated with Pathogenic Variants in JAG2

    The authors described muscular dystrophy associated with pathogenic variants in JAG2 and suggested a disease mechanism related to Notch pathway dysfunction.
    [American Journal of Human Genetics]

    Abstract

    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    PUBLICATIONSRanked by the impact factor of the journal

    Ligand-Activated RXFP1 Gene Therapy Ameliorates Pressure Overload-Induced Cardiac Dysfunction

    In vitro, relaxin stimulation of relaxin family peptide receptor 1 (RXFP1) – expressing cardiomyocytes induced downstream signaling resulting in PKA-specific phosphorylation of phospholamban, which was distinguishable from β-adrenergic activation.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Overexpression of circRNA SNRK Targets miR-103-3p to Reduce Apoptosis and Promote Cardiac Repair Through GSK3β/β-Catenin Pathway in Rats with Myocardial Infarction

    circRNA regulated cardiomyocyte apoptosis and proliferation by acting as a miR-103-3p sponge and inducing increased expression of SNRK which could bind GSK3β to regulate its phosphorylated activity.
    [Cell Death Discovery]

    Full Article

    Base Editing Repairs an SGCA Mutation in Human Primary Muscle Stem Cells

    Investigators provided the first evidence that autologous gene repaired human muscle stem cells could be harnessed for cell replacement therapies of muscular dystrophies.
    [JCI Insight]

    AbstractGraphical Abstract

    Modeling Muscle Regeneration in RNA Toxicity Mice

    Using a BaCl2 induced damage model, researchers found that RNA toxicity led to decreased expression of PAX7, and decreased numbers of satellite cells, the stem cells of adult skeletal muscle .
    [Human Molecular Genetics]

    Abstract

    Valdecoxib Improves Lipid-Induced Skeletal Muscle Insulin Resistance via Simultaneous Suppression of Inflammation and Endoplasmic Reticulum Stress

    Scientists suggest that valdecoxib alleviated insulin resistance through AMP-activated protein kinase/heat shock protein beta 1-mediated inhibition of inflammation and endoplasmic reticulum stress in skeletal muscle under hyperlipidemic conditions.
    [Biochemical Pharmacology]

    AbstractGraphical Abstract

    FAK in the Nucleus Prevents VSMC Proliferation by Promoting p27 and p21 Expression via Skp2 Degradation

    Both pharmacological focal adhesion kinase (FAK) and genetic FAK inhibition reduced S-phase kinase-associated protein 2 (Skp2) expression in Vascular smooth muscle cells (VSMCs) upon injury, which significantly reduced intimal hyperplasia through elevated expression of p27 and p21.
    [Cardiovascular Research]

    AbstractGraphical Abstract

    Loss of Transforming Growth Factor Beta Signaling in Aortic Smooth Muscle Cells Causes Endothelial Dysfunction and Aortic Hypercontractility

    Scientists investigated whether loss of SMC TGF-β signaling in mice alters aortic contractile-protein levels and aortic contractility.
    [Arteriosclerosis Thrombosis and Vascular Biology]

    Abstract

    CHOP Increases TRIB3-Dependent miR-208 Expression to Potentiate Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating TIMP3 in Atherosclerosis

    The authors showed that inhibition of C/EBP homologous protein (CHOP) might inhibit the proliferation and migration of vascular smooth muscle cells as well as reduce the levels of TC, TG, and LDL-C but increase the level of HDL-C through the tribbles homologue 33/microRNA-208/tissue inhibitor of metalloproteinases-3 (TIMP3) axis, thereby inhibiting the progression of atherosclerosis.
    [Cardiovascular Drugs and Therapy]

    Abstract

    Functional NMDA Receptors Are Expressed By Human Pulmonary Artery Smooth Muscle Cells

    Researchers demonstrate that both GluN1 and GluN2 subunit mRNAs were expressed in human pulmonary artery. They found GluN1 and GluN2 (A–D) subunit proteins were expressed by human pulmonary artery smooth muscle cells in vitro and in vivo.
    [Scientific Reports]

    Full Article

    ON820MYO-Cardiac Podcast_645x110 - Cardiomyocytes
    REVIEWS

    The Relationship between Muscle Stem Cells and Motor Neurons

    Scientists discuss the relationship between muscle stem cells and motor neurons during Drosophila neuromuscular system development and adverse impact of affected muscle stem cell–motor neuron interactions in regenerating vertebrate muscle.
    [Cellular and Molecular Life Sciences]

    Abstract

    A New Trick for an Old Dog? Myocardial-Specific Roles for Prostaglandins as Mediators of Ischemic Injury and Repair

    The authors highlight both the key historical studies that underpin modern prostaglandin research in the heart, while concurrently presenting the latest findings related to how prostaglandin metabolism and signalling impact myocardial injury and repair.
    [American Journal of Physiology-Heart and Circulatory Physiology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Continued Improvements in Motor Milestones in Infants with Type I Spinal Muscular Atrophy After Two Years of Treatment with Evrysdiâ„¢

    PTC Therapeutics, Inc. announced that results from Part II of the pivotal FIREFISH trial demonstrated that infants with type 1 spinal muscular atrophy treated with Evrysdiâ„¢ obtained increases in survival and sustained improvements in achieving key motor milestones, including head control, sitting, rolling over, and further developing towards acquiring the ability to stand, and walk.
    [PTC THerapeutics, Inc.]

    Press Release

    Actimed Therapeutics and Faraday Pharmaceuticals Announce License Agreement for S-oxprenolol

    Actimed Therapeutics Ltd., announced a license agreement for S-oxprenolol to Faraday Pharmaceuticals, Inc. S-oxprenolol is one of a new class of anabolic-catabolic transforming agents under development by Actimed.
    [Actimed Therapeutics Ltd.]

    Press Release

    FEATURED EVENT

    EMBO Workshop: Long-Distance Cell-Cell Signaling in Development and Disease

    September 5 – 8, 2021
    Exeter, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Research Laboratory Tech Associate – Muscular Dystrophies

    University of Michigan – Ann Arbor, Michigan, United States

    Research Scientist – Muscle Tissue Engineering

    Aspect Biosystems – Vancouver, British Columbia, Canada

    Life Sciences Researcher – Muscle Stem Cell

    Stanford University – Stanford, California, United States

    Associate Researcher – Developmental and Regenerative Biology

    Mount Sinai Health System – New York, New York, United States

    Postdoctoral Position – Cardiovascular Research

    Albert Einstein College of Medicine – Bronx, New York, United States

    > See All Jobs

    Submit (1)
    Brought to you by
    stemcell-logo-for newsletter-2
    Muscle Cell News Twitter